Jiangsu Yahong Meditech Co., Ltd. engages in the research, development, production and commercialization of medicines in the fields of urogenital system tumors and other major disease areas. It provides urinary tract, reproductive system diseases, bladder cancer, and other illnesses treatment. The company was founded by Pan Ke on March 16, 2010 and is headquartered in Shanghai, China.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company